Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 11 non-open-market transactions below 12 months to the week close of 2026-10-23

Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

11 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Dec. 5, 2017 SYRE P 10,241 $4.76 $48,747 34,787 Direct +41.72% Acquired -24.1% (price as of )
Dec. 4, 2017 SYRE P 3,259 $4.97 $16,197 24,546 Direct +15.31% Acquired -27.3% (price as of )
Dec. 1, 2017 SYRE P 6,500 $4.59 $29,835 21,287 Direct +43.96% Acquired -21.3% (price as of )
Aug. 15, 2017 SYRE P 1,959 $2.52 $4,937 14,787 Direct +15.27% Acquired 43.4% (price as of )
Feb. 15, 2017 SYRE P 2,000 $4.28 $8,560 12,828 Direct +18.47% Acquired -15.6% (price as of )
Aug. 15, 2016 SYRE P 2,000 $3.99 $7,980 10,828 Direct +22.66% Acquired -9.4% (price as of )

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 14, 2020 SYRE Employee Stock Option (right to buy) Common Stock (126,000) $8.15 Feb. 13, 2030 126,000 Acquired
Feb. 28, 2019 SYRE Employee Stock Option (right to buy) Common Stock (87,600) $8.36 Feb. 27, 2029 87,600 Acquired
Feb. 20, 2018 SYRE Employee Stock Option (right to buy) Common Stock (92,100) $6.31 Feb. 19, 2028 92,100 Acquired
Aug. 22, 2017 SYRE Employee Stock Option (right to buy) Common Stock (58,500) $3.10 Aug. 21, 2027 58,500 Acquired
March 20, 2017 SYRE Employee Stock Option (right to buy) Common Stock (90,000) $8.03 March 19, 2027 90,000 Acquired
May 17, 2016 SYRE Employee Stock Option (right to buy) Common Stock (55,000) $7.28 May 16, 2026 55,000 Acquired
April 12, 2016 SYRE Series B Preferred Stock Common Stock (1,324) · · 1,324 Disposed
April 12, 2016 SYRE Series A Preferred Stock Common Stock (9,523) · · 9,523 Disposed
April 12, 2016 SYRE Series B Preferred Stock Common Stock (2,037) · · 2,037 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 7 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
April 6, 2016 SYRE Common Stock 7,504 Direct
April 6, 2016 SYRE Series A Preferred Stock→ Common Stock (9,523) 9,523 Indirect
April 6, 2016 SYRE Series B Preferred Stock→ Common Stock (2,037) 2,037 Indirect
April 6, 2016 SYRE Series B Preferred Stock→ Common Stock (1,324) 1,324 Direct
April 6, 2016 SYRE Employee Stock Option (right to buy)→ Common Stock (10,183) 10,183 Direct
April 6, 2016 SYRE Employee Stock Option (right to buy)→ Common Stock (22,258) 22,258 Direct
April 6, 2016 SYRE Employee Stock Option (right to buy)→ Common Stock (15,027) 15,027 Direct

Compensation (DEF 14A)

10

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2020 $415,000 · · · · · $8,053 $1,283,468
2019 $390,000 · · · $165,000 · $7,712 $1,085,136
2018 $343,000 $185,000 · · · · $7,981 $960,823

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.